Abstract
IFN-γ was originally characterized as a proinflammatory cytokine with T helper type 1 inducing activity, but it is now clear that it also has important immunoregulatory functions. Regulatory T cells play an important role in models of autoimmunity, GVHD, and transplantation, and offer potential as a cellular therapy. In rodent models, in vivo-generated CD25+CD4+ T cells can prevent allograft rejection, but therapeutic exploitation of Treg will more likely depend on protocols that allow the generation or selection of Treg ex vivo. The experiments described in this chapter will show that alloantigen-reactive Treg can be generated/expanded ex vivo using IFN-γ, a cytokine more usually associated with allograft rejection. Although IFN-γ production has hitherto been generally regarded as nonpermissive for allograft survival, we believe this paradoxical “good–bad” role for IFN-γ may reflect an important physiological negative feedback loop.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Weaver, C.T., Hatton, R.D., Mangan, P.R. and Harrington, L.E. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol., 25, 821–852.
Ferber, I., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. and Fathman, C. (1996) Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol., 156, 5–7.
Chu, C.-Q., Wittmer, S. and Dalton, D.K. (2000) Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med., 192, 123–128.
Willenborg, D.O., Fordham, S.A., Staykova, M.A., Ramshaw, I.A. and Cowden, W.B. (1999) IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol., 163, 5278–5286.
Manoury-Schwartz, B., Chiocchia, G., Bessis, N., Abehsira-Amar, O., Batteux, F., Muller, S., Huang, S., Boissier, M.C. and Fournier, C. (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J. Immunol., 158, 5501–5506.
Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A. and Matthys, P. (1997) Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J. Immunol., 158, 5507–5513.
Ortmann, R.A. and Shevach, E.M. (2001) Susceptibility to collagen-induced arthritis: cytokine-mediated regulation. Clin. Immunol., 98, 109–118.
Brem-Exner, B.G., Sattler, C., Hutchinson, J.A., Koehl, G.E., Kronenberg, K., Farkas, S., Inoue, S., Blank, C., Knechtle, S.J., Schlitt, H.J. et al. (2008) Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J. Immunol., 180, 335–349.
Boehm, U., Klamp, T., Groot, M. and Howard, J.C. (1997) Cellular responses to interferon-gamma. Annu. Rev. Immunol., 15, 749–795.
O’Garra, A. (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity, 8, 275–283.
Gajewski, T. and Fitch, F. (1988) Anti-proliferative effect of IFN-γ in immune regulation. I. IFN- gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol., 140, 4245–4252.
Park, H., Li, Z., Yang, X.O., Chang, S.H., Nurieva, R., Wang, Y.H., Wang, Y., Hood, L., Zhu, Z., Tian, Q. et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol., 6, 1133–1141.
Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M. and Weaver, C.T. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol., 6, 1123–1132.
Liu, Y. and Janeway, C., Jr. (1990) Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp. Med., 172, 1735–1739.
Dalton, D.K., Haynes, L., Chu, C.-Q., Swain, S.L. and Wittmer, S. (2000) Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med., 192, 117–122.
Refaeli, Y., Van Parijs, L., Alexander, S.I. and Abbas, A.K. (2002) Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med., 196, 999–1005.
Feuerer, M., Eulenburg, K., Loddenkemper, C., Hamann, A. and Huehn, J. (2006) Self-limitation of Th1-mediated inflammation by IFN-γ. J. Immunol., 176, 2857–2863.
Berner, V., Liu, H., Zhou, Q., Alderson, K.L., Sun, K., Weiss, J.M., Back, T.C., Longo, D.L., Blazar, B.R., Wiltrout, R.H. et al. (2007) IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat. Med., 13, 354–360.
Li, X., McKinstry, K.K., Swain, S.L. and Dalton, D.K. (2007) IFN-γ acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol., 179, 939–949.
Sawitzki, B., Kingsley, C.I., Oliveira, V., Karim, M., Herber, M. and Wood, K.J. (2005) IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med., 201, 1925–1935.
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M.L., Bianchi, R., Fioretti, M.C. et al. (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol., 3, 1097–1101.
Finger, E.B. and Bluestone, J.A. (2002) When ligand becomes receptor – tolerance via B7 signaling on DCs. Nat. Immunol., 3, 1056–1057.
Mellor, A.L. and Munn, D.H. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol., 4, 762–774.
Markees, T.G., Phillips, N.E., Gordon, E.J., Noelle, R.J., Shultz, L.D., Mordes, J.P., Greiner, D.L. and Rossini, A.A. (1998) Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+ T cells, interferon-γ, and CTLA4. J. Clin. Invest., 101, 2446–2455.
Fairchild, R.L. (2003) The Yin and Yang of IFN-γ in allograft rejection. Am. J. Transplant., 3, 913–914.
Wood, K.J. and Sawitzki, B. (2006) Interferon γ: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol., 27, 183–187.
Bugeon, L., Cuturi, M.C., Hallet, M.M., Paineau, J., Chabannes, D. and Soulillou, J.P. (1992) Peripheral tolerance of an allograft in adult rats-characterization by low interleukin-2 and interferon-γ mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation, 54, 219–225.
Nickerson, P., Steiger, J., Zheng, X.X., Steele, A.W., Steurer, W., Roy-Chaudhury, P. and Strom, T.B. (1997) Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation, 63, 489–494.
Saleem, S., Konieczny, B.T., Lowry, R.P., Baddoura, F.K. and Lakkis, F.G. (1996) Acute rejection of vascularized heart allografts in the absence of IFN-γ. Transplantation, 62, 1908–1911.
Bishop, D.K., Wood, S.C., Eichwald, E.J. and Orosz, C.G. (2001) Immunobiology of allograft rejection in the absence of IFN-γ: CD8+ effector cells develop independently of CD4+ cells and CD40–CD40 ligand interactions. J. Immunol., 166, 3248–3255.
Konieczny, B.T., Dai, Z., Elwood, E.T., Saleem, S., Linsley, P.S., Baddoura, F.K., Larsen, C.P., Pearson, T.C. and Lakkis, F.G. (1998) IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol., 160, 2059–2064.
Guillonneau, C., Hill, M., Hubert, F.-X., Chiffoleau, E., Herve, C., Li, X.-L., Heslan, M., Usal, C., Tesson, L., Menoret, S. et al. (2007) CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenase. J. Clin. Invest., 117, 1096–1106.
Qin, S., Wise, M., Cobbold, S., Leong, L., Kong, Y., Parnes, J. and Waldmann, H. (1990) Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol., 20, 2737–2745.
Bhattacharya, A., Dorf, M. and Springer, T. (1981) A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol., 127, 2488–2495.
Springer, T., Galfre, G., Secher, D.S. and Milstein, C. (1978) Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur. J. Immunol., 8, 539–551.
Asensi, V., Kimeno, K., Kawamura, I., Sakumoto, M. and Nomoto, K. (1989) Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies. Immunology, 68, 204–208.
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R.M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med., 176, 1693–1702.
Yamaguchi, Y., Tsumura, H., Miwa, M. and Inaba, K. (1997) Contrasting effects of TGF-β1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells, 15, 144–153.
Fontenot, J.D., Gavin, M.A. and Rudensky, A.Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol., 4, 330–336.
Hori, S., Nomura, T. and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057–1061.
Khattri, R., Cox, T., Yasayko, S.-A. and Ramsdell, F. (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol., 4, 337–342.
Hsieh, C., Macatonia, S., O’Garra, A. and Murphy, K. (1995) T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med., 181, 713–721.
Jonuleit, H., Schmitt, E., Steinbrink, K. and Enk, A.H. (2001) Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol., 22, 394–400.
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L. and Kuchroo, V.K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441, 235–238.
Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M.C. and von Boehmer, H. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol., 6, 1219–1227.
Ohmori, H. and Yamamoto, I. (1982) Mechanism of augmentation of the antibody response in vitro by 2- mercaptoethanol in murine lymphocytes. I. 2-Mercaptoethanol-induced stimulation of the uptake of cystine, an essential amino acid. J. Exp. Med., 155, 1277–1290.
Zmuda, J. and Friedenson, B. (1983) Changes in intracellular glutathione levels in stimulated and unstimulated lymphocytes in the presence of 2-mercaptoethanol or cysteine. J. Immunol., 130, 362–364.
Pruett, S.B., Obiri, N. and Kiel, J.L. (1989) Involvement and relative importance of at least two distinct mechanisms in the effects of 2-mercaptoethanol on murine lymphocytes in culture. J. Cell. Physiol., 141, 40–45.
Duhe, R.J., Evans, G.A., Erwin, R.A., Kirken, R.A., Cox, G.W. and Farrar, W.L. (1998) Nitric oxide and thiol redox regulation of Janus kinase activity. Proc. Natl. Acad. Sci. U. S. A., 95, 126–131.
Bevan, M.J., Epstein, R. and Cohn, M. (1974) The effect of 2-mercaptoethanol on murine mixed lymphocyte culture. J. Exp. Med., 139, 1025–1030.
Goodman, M. and Weigle, W. (1977) Nonspecific activation of murine lymphocytes. I. Proliferation and polyclonal activation induced by 2-mercaptoethanol and alpha- thioglycerol. J. Exp. Med., 145, 473–489.
Feng, G., Gao, W., Strom, T.B., Oukka, M., Francis, R.S., Wood, K.J. and Bushell, A. (2008) Exogenous IFN-γ ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells. Eur. J. Immunol., 38, 2512–2527.
Lipoldova, M. and Demant, P. (2006) Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat. Rev. Genet., 7, 294–305.
Williams, M.A., Trambley, J., Ha, J., Adams, A.B., Durham, M.M., Rees, P., Cowan, S.R., Pearson, T.C. and Larsen, C.P. (2000) Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J. Immunol., 165, 6849–6857.
Himmelrich, H., Parra-Lopez, C., Tacchini-Cottier, F., Louis, J.A. and Launois, P. (1998) The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. J. Immunol., 161, 6156–6163.
Yagi, R., Suzuki, W., Seki, N., Kohyama, M., Inoue, T., Arai, T. and Kubo, M. (2002) The IL-4 production capability of different strains of naive CD4+ T cells controls the direction of the Th cell response. Int. Immunol., 14, 1–11.
Noben-Trauth, N., Hu-Li, J. and Paul, W.E. (2000) Conventional, naive CD4+ T cells provide an initial source of IL-4 during Th2 differentiation. J. Immunol., 165, 3620–3625.
Feng, G., Wood, K.J. and Bushell, A. (2008) IFN-γ conditioning ex-vivo generates CD25+CD62L+ Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation, 86, 578–589.
Acknowledgments
This work was supported by The Wellcome Trust and British Heart Foundation. G. F. received a Dorothy Hodgkin Postgraduate Award and support from The China-Oxford Scholarship Fund. K. J. W. holds a Royal Society Wolfson Research Merit Award.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press
About this protocol
Cite this protocol
Feng, G., Wood, K.J., Bushell, A. (2010). Regulatory T Cell Enrichment by IFN-γ Conditioning. In: Cuturi, M., Anegon, I. (eds) Suppression and Regulation of Immune Responses. Methods in Molecular Biology, vol 677. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-869-0_20
Download citation
DOI: https://doi.org/10.1007/978-1-60761-869-0_20
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-868-3
Online ISBN: 978-1-60761-869-0
eBook Packages: Springer Protocols